Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Epidermal autonomous VEGFA/Flt1/Nrp1 functions mediate psoriasis-like disease.

Benhadou F, Glitzner E, Brisebarre A, Swedlund B, Song Y, Dubois C, Rozzi M, Paulissen C, Del Marmol V, Sibilia M, Blanpain C.

Sci Adv. 2020 Jan 8;6(2):eaax5849. doi: 10.1126/sciadv.aax5849. eCollection 2020 Jan.

2.

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2019.

Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Bastholt L, Bataille V, Del Marmol V, Dréno B, Fargnoli MC, Grob JJ, Höller C, Kaufmann R, Lallas A, Lebbé C, Malvehy J, Middleton M, Moreno-Ramirez D, Pellacani G, Saiag P, Stratigos AJ, Vieira R, Zalaudek I, Eggermont AMM; European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC).

Eur J Cancer. 2020 Feb;126:141-158. doi: 10.1016/j.ejca.2019.11.014. Epub 2020 Jan 9.

3.

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2019.

Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Bastholt L, Bataille V, Del Marmol V, Dréno B, Fargnoli MC, Grob JJ, Höller C, Kaufmann R, Lallas A, Lebbé C, Malvehy J, Middleton M, Moreno-Ramirez D, Pellacani G, Saiag P, Stratigos AJ, Vieira R, Zalaudek I, Eggermont AMM; European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC).

Eur J Cancer. 2020 Feb;126:159-177. doi: 10.1016/j.ejca.2019.11.015. Epub 2019 Dec 19.

4.

The actinic dysplasia syndrome - diagnostic approaches defining a new concept in field carcinogenesis with multiple cSCC.

Dejonckheere G, Suppa M, Del Marmol V, Meyer T, Stockfleth E.

J Eur Acad Dermatol Venereol. 2019 Dec;33 Suppl 8:16-20. doi: 10.1111/jdv.15949. Review.

PMID:
31833608
5.

Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy.

Seremet T, Jansen Y, Planken S, Njimi H, Delaunoy M, El Housni H, Awada G, Schwarze JK, Keyaerts M, Everaert H, Lienard D, Del Marmol V, Heimann P, Neyns B.

J Transl Med. 2019 Sep 5;17(1):303. doi: 10.1186/s12967-019-2051-8.

6.

A narrative review of the definition of 'flare' in hidradenitis suppurativa.

Kirby JS, Moore B, Leiphart P, Shumaker K, Mammis-Gierbolini A, Benhadou F, Del Marmol V.

Br J Dermatol. 2020 Jan;182(1):24-28. doi: 10.1111/bjd.18035. Epub 2019 Jul 28. Review.

PMID:
31025310
7.

Pilonidal sinus disease: an intergluteal localization of hidradenitis suppurativa/acne inversa: a cross-sectional study among 2465 patients.

Benhadou F, Van der Zee HH, Pascual JC, Rigopoulos D, Katoulis A, Liakou AI, Daxhelet M, Romanelli M, Iannone M, Kinyó Á, Nikolakis G, Zouboulis CC, Dessinioti C, Zisimou C, Antoniou C, Alavi A, Mintoff D, Aquilina S, Matusiak L, Szepietowski JC, Sinclair R, Husein-ElAhmed H, von Laffert M, Revuz J, Danby B, Puig L, Theut Riis P, Jemec GBE, van van Straalen K, Wigny KMGJ, Del Marmol V, Guillem P.

Br J Dermatol. 2019 Dec;181(6):1198-1206. doi: 10.1111/bjd.17927. Epub 2019 May 6.

PMID:
30919434
8.

Management of Kaposi sarcoma after solid organ transplantation: A European retrospective study.

Delyon J, Rabate C, Euvrard S, Harwood CA, Proby C, Güleç AT, Seçkin D, Del Marmol V, Bouwes-Bavinck JN, Ferrándiz-Pulido C, Ocampo MA, Barete S, Legendre C, Francès C, Porcher R, Lebbe C; Skin Care in Organ Transplant Patients Europe (SCOPE) group.

J Am Acad Dermatol. 2019 Aug;81(2):448-455. doi: 10.1016/j.jaad.2019.03.028. Epub 2019 Mar 19.

PMID:
30902727
9.

Prevalence and determinants of sunbed use in thirty European countries: data from the Euromelanoma skin cancer prevention campaign.

Suppa M, Gandini S, Njimi H, Bulliard JL, Correia O, Duarte AF, Peris K, Stratigos AJ, Nagore E, Longo MI, Bylaite-Bucinskiene M, Karls R, Helppikangas H; Euromelanoma Working Group,, Del Marmol V.

J Eur Acad Dermatol Venereol. 2019 Mar;33 Suppl 2:13-27. doi: 10.1111/jdv.15311.

PMID:
30811698
10.

Sunbeds: An international common concern.

Augustin M, Del Marmol V.

J Eur Acad Dermatol Venereol. 2019 Mar;33 Suppl 2:5. doi: 10.1111/jdv.15410. No abstract available.

PMID:
30811697
11.

Overview on vitamin D and sunbed use.

Pierret L, Suppa M, Gandini S, Del Marmol V, Gutermuth J.

J Eur Acad Dermatol Venereol. 2019 Mar;33 Suppl 2:28-33. doi: 10.1111/jdv.15316. Review.

PMID:
30811696
12.

Sunbed use legislation in Europe: assessment of current status.

Longo MI, Bulliard JL, Correia O, Maier H, Magnússon SM, Konno P, Goad N, Duarte AF, Oláh J, Nilsen LTN, Peris K, Karls R, Forsea AM, Del Marmol V.

J Eur Acad Dermatol Venereol. 2019 Mar;33 Suppl 2:89-96. doi: 10.1111/jdv.15317.

PMID:
30811694
13.

Who, why, where: an overview of determinants of sunbed use in Europe.

Suppa M, Gandini S, Bulliard JL, Daxhelet M, Zamagni M, Forsea AM, Longo MI, Del Marmol V.

J Eur Acad Dermatol Venereol. 2019 Mar;33 Suppl 2:6-12. doi: 10.1111/jdv.15318. Review.

PMID:
30811690
14.

Association of sunbed use with skin cancer risk factors in Europe: an investigation within the Euromelanoma skin cancer prevention campaign.

Suppa M, Gandini S, Njimi H, Bulliard JL, Correia O, Duarte AF, Peris K, Stratigos AJ, Nagore E, Longo MI, Bylaite-Bucinskiene M, Karls R, Helppikangas H; Euromelanoma Working Group,, Del Marmol V.

J Eur Acad Dermatol Venereol. 2019 Mar;33 Suppl 2:76-88. doi: 10.1111/jdv.15307.

PMID:
30811689
15.

Sunbed use in Europe: Time for information.

Del Marmol V, Stratigos A, Calzavara-Pinton P, Augustin M.

J Eur Acad Dermatol Venereol. 2019 Mar;33 Suppl 2:3. doi: 10.1111/jdv.15310. No abstract available.

PMID:
30811687
16.

Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.

Thorlacius L, Garg A, Riis PT, Nielsen SM, Bettoli V, Ingram JR, Del Marmol V, Matusiak L, Pascual JC, Revuz J, Sartorius K, Tzellos T, van der Zee HH, Zouboulis CC, Saunte DM, Gottlieb AB, Christensen R, Jemec GBE.

Br J Dermatol. 2019 Sep;181(3):483-491. doi: 10.1111/bjd.17716. Epub 2019 Jun 6.

PMID:
30724351
17.

Editorial: New Frontiers in Skin Cancer.

Del Marmol V, Stratigos AJ.

Curr Opin Oncol. 2019 Mar;31(2):53. doi: 10.1097/CCO.0000000000000509. No abstract available.

PMID:
30720475
18.

New perspectives in Merkel cell carcinoma.

Del Marmol V, Lebbé C.

Curr Opin Oncol. 2019 Mar;31(2):72-83. doi: 10.1097/CCO.0000000000000508. Review.

PMID:
30694842
19.

Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go?

De Bruyn P, Van Gestel D, Ost P, Kruse V, Brochez L, Van Vlierberghe H, Devresse A, Del Marmol V, Le Moine A, Aspeslagh S.

Curr Opin Oncol. 2019 Mar;31(2):54-64. doi: 10.1097/CCO.0000000000000505. Review.

PMID:
30694841
20.

Psoriasis: Keratinocytes or Immune Cells - Which Is the Trigger?

Benhadou F, Mintoff D, Del Marmol V.

Dermatology. 2019;235(2):91-100. doi: 10.1159/000495291. Epub 2018 Dec 19. Review.

21.

Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients.

Lanz J, Bouwes Bavinck JN, Westhuis M, Quint KD, Harwood CA, Nasir S, Van-de-Velde V, Proby CM, Ferrándiz C, Genders RE, Del Marmol V, Forchetti G, Hafner J, Vital DG, Hofbauer GFL.

JAMA Dermatol. 2019 Jan 1;155(1):66-71. doi: 10.1001/jamadermatol.2018.4406.

22.

Anaphylaxis-like reaction to anti-BRAF inhibitor dabrafenib confirmed by drug provocation test.

Seremet T, Haccuria A, Lienard D, Del Marmol V, Neyns B.

Melanoma Res. 2019 Feb;29(1):95-98. doi: 10.1097/CMR.0000000000000529.

PMID:
30383722
23.

Line-field confocal optical coherence tomography for high-resolution noninvasive imaging of skin tumors.

Dubois A, Levecq O, Azimani H, Siret D, Barut A, Suppa M, Del Marmol V, Malvehy J, Cinotti E, Rubegni P, Perrot JL.

J Biomed Opt. 2018 Oct;23(10):1-9. doi: 10.1117/1.JBO.23.10.106007.

24.

[New therapeutic approaches for hidradenitis suppurativa].

Suppa M, Benhadou F, Daxhelet M, Del Marmol V.

Rev Med Brux. 2018;39(4):367-371. Review. French.

PMID:
30321002
25.

A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy.

Sánchez-Danés A, Larsimont JC, Liagre M, Muñoz-Couselo E, Lapouge G, Brisebarre A, Dubois C, Suppa M, Sukumaran V, Del Marmol V, Tabernero J, Blanpain C.

Nature. 2018 Oct;562(7727):434-438. doi: 10.1038/s41586-018-0603-3. Epub 2018 Oct 8.

26.

Successful treatment with intralesional talimogene laherparepvec in two patients with immune checkpoint inhibitor-refractory, advanced-stage melanoma.

Seremet T, Planken S, Schwarze JK, Jansen Y, Vandeweerd L, van den Begin R, Tsechelidis I, Lienard D, Del Marmol V, Neyns B.

Melanoma Res. 2019 Feb;29(1):85-88. doi: 10.1097/CMR.0000000000000501.

PMID:
30211812
27.

Low Back Pain in Hidradenitis Suppurativa: A Diagnosis Not to Miss!

Schnebert B, Del Marmol V, Benhadou F.

Case Rep Dermatol. 2018 Jul 12;10(2):187-189. doi: 10.1159/000490880. eCollection 2018 May-Aug.

28.

Euromelanoma in Portugal. How useful was the Euromelanoma campaign between 2010 and 2017?

Correia O, Duarte AF, Del Marmol V, Picoto A.

Int J Dermatol. 2018 Oct;57(10):e85-e88. doi: 10.1111/ijd.14179. Epub 2018 Aug 9. No abstract available.

PMID:
30091456
29.

Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results.

Dantal J, Morelon E, Rostaing L, Goffin E, Brocard A, Tromme I, Broeders N, Del Marmol V, Chatelet V, Dompmartin A, Kessler M, Serra A, Hofbauer GFL, Kamar N, Pouteil-Noble C, Kanitakis J, Roux A, Decullier E, Euvrard S; TUMORAPA Study Group.

J Clin Oncol. 2018 Sep 1;36(25):2612-2620. doi: 10.1200/JCO.2017.76.6691. Epub 2018 Jul 17.

PMID:
30016177
30.

Acute Erythroderma in a Patient Receiving TNF-α-Blocking Therapy for Hidradenitis Suppurativa.

Benhadou F, Hellgren G, Willaert F, Del Marmol V.

Case Rep Dermatol. 2018 Jan 31;10(1):7-12. doi: 10.1159/000485911. eCollection 2018 Jan-Apr.

31.

ECCO essential requirements for quality cancer care: Melanoma.

Wouters MW, Michielin O, Bastiaannet E, Beishon M, Catalano O, Del Marmol V, Delgado-Bolton R, Dendale R, Trill MD, Ferrari A, Forsea AM, Kreckel H, Lövey J, Luyten G, Massi D, Mohr P, Oberst S, Pereira P, Prata JPP, Rutkowski P, Saarto T, Sheth S, Spurrier-Bernard G, Vuoristo MS, Costa A, Naredi P.

Crit Rev Oncol Hematol. 2018 Feb;122:164-178. doi: 10.1016/j.critrevonc.2017.12.020. Epub 2018 Jan 2. Review.

32.

Stellenwert der Dermatoskopie in Deutschland - Ergebnisse aus der Pan-Euro-Dermoscopy-Querschnittsstudie.

Blum A, Kreusch J, Stolz W, Argenziano G, Forsea AM, Marmol V D, Zalaudek I, Soyer HP, Haenssle HA.

J Dtsch Dermatol Ges. 2018 Feb;16(2):174-182. doi: 10.1111/ddg.13431_g. No abstract available.

PMID:
29418098
33.

The status of dermoscopy in Germany - results of the cross-sectional Pan-Euro-Dermoscopy Study.

Blum A, Kreusch J, Stolz W, Argenziano G, Forsea AM, Marmol V D, Zalaudek I, Soyer HP, Haenssle HA.

J Dtsch Dermatol Ges. 2018 Feb;16(2):174-181. doi: 10.1111/ddg.13431. Epub 2018 Jan 31.

PMID:
29384261
34.

Illustrative cases for monitoring by quantitative analysis of BRAF/NRAS ctDNA mutations in liquid biopsies of metastatic melanoma patients who gained clinical benefits from anti-PD1 antibody therapy.

Seremet T, Planken S, Schreuer M, Jansen Y, Delaunoy M, El Housni H, Lienard D, Del Marmol V, Heimann P, Neyns B.

Melanoma Res. 2018 Feb;28(1):65-70. doi: 10.1097/CMR.0000000000000415.

PMID:
29227333
35.

Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version.

Kanti V, Messenger A, Dobos G, Reygagne P, Finner A, Blumeyer A, Trakatelli M, Tosti A, Del Marmol V, Piraccini BM, Nast A, Blume-Peytavi U.

J Eur Acad Dermatol Venereol. 2018 Jan;32(1):11-22. doi: 10.1111/jdv.14624. Epub 2017 Nov 27.

PMID:
29178529
36.

Clinical assessment of skin phototypes: watch your words!

Trakatelli M, Bylaite-Bucinskiene M, Correia O, Cozzio A, De Vries E, Medenica L, Nagore E, Paoli J, Stratigos AJ, Del Marmol V, Bulliard JL.

Eur J Dermatol. 2017 Dec 1;27(6):615-619. doi: 10.1684/ejd.2017.3129.

37.

Low and high body mass index in hidradenitis suppurativa patients-different subtypes?

Theut Riis P, Saunte DM, Benhadou F, Del Marmol V, Guillem P, El-Domyati M, Abdel-Wahab H, Antoniou C, Dessinioti C, Gürer MA, Beksaç B, Szepietowski JC, Matusiak L, Emtestam L, Lapins J, Riad H, Doss N, Massa AF, Hamzavi I, Nicholson C, Dolenc-Voljc M, Kim KH, Ohn J, Zouboulis CC, Karagiannidis I, Mokos ZB, Durinec P, Jemec GBE.

J Eur Acad Dermatol Venereol. 2018 Feb;32(2):307-312. doi: 10.1111/jdv.14599. Epub 2017 Oct 10.

PMID:
28940801
38.

Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.

Zouboulis CC, Tzellos T, Kyrgidis A, Jemec GBE, Bechara FG, Giamarellos-Bourboulis EJ, Ingram JR, Kanni T, Karagiannidis I, Martorell A, Matusiak Ł, Pinter A, Prens EP, Presser D, Schneider-Burrus S, von Stebut E, Szepietowski JC, van der Zee HH, Wilden SM, Sabat R; European Hidradenitis Suppurativa Foundation Investigator Group.

Br J Dermatol. 2017 Nov;177(5):1401-1409. doi: 10.1111/bjd.15748. Epub 2017 Oct 30.

PMID:
28636793
39.

Overlapping DRESS and Stevens-Johnson Syndrome: Case Report and Review of the Literature.

Casagranda A, Suppa M, Dehavay F, Del Marmol V.

Case Rep Dermatol. 2017 May 8;9(2):1-7. doi: 10.1159/000475802. eCollection 2017 May-Aug.

40.

[Multiple and recurrent cutaneous abscesses: diagnosis approach].

Sène N, Del Marmol V.

Rev Med Brux. 2017;38(1):26-32. Review. French.

PMID:
28525198
41.

Frontal fibrosing alopecia in men: an association with facial moisturizers and sunscreens.

Debroy Kidambi A, Dobson K, Holmes S, Carauna D, Del Marmol V, Vujovic A, Kaur MR, Takwale A, Farrant P, Champagne C, Harries M, Messenger AG.

Br J Dermatol. 2017 Jul;177(1):260-261. doi: 10.1111/bjd.15311. Epub 2017 May 23. No abstract available.

42.

The impact of dermoscopy on melanoma detection in the practice of dermatologists in Europe: results of a pan-European survey.

Forsea AM, Tschandl P, Zalaudek I, Del Marmol V, Soyer HP; Eurodermoscopy Working Group, Argenziano G, Geller AC.

J Eur Acad Dermatol Venereol. 2017 Jul;31(7):1148-1156. doi: 10.1111/jdv.14129. Epub 2017 Feb 21.

PMID:
28109068
43.

Public primary and secondary skin cancer prevention, perceptions and knowledge: an international cross-sectional survey.

Seité S, Del Marmol V, Moyal D, Friedman AJ.

J Eur Acad Dermatol Venereol. 2017 May;31(5):815-820. doi: 10.1111/jdv.14104. Epub 2017 Feb 8.

44.

Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology.

Dirschka T, Gupta G, Micali G, Stockfleth E, Basset-Séguin N, Del Marmol V, Dummer R, Jemec GBE, Malvehy J, Peris K, Puig S, Stratigos AJ, Zalaudek I, Pellacani G.

J Dermatolog Treat. 2017 Aug;28(5):431-442. doi: 10.1080/09546634.2016.1254328. Epub 2016 Nov 13. Review.

45.

Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional study.

Deckers IE, Benhadou F, Koldijk MJ, Del Marmol V, Horváth B, Boer J, van der Zee HH, Prens EP.

J Am Acad Dermatol. 2017 Jan;76(1):49-53. doi: 10.1016/j.jaad.2016.08.031. Epub 2016 Oct 25.

PMID:
27793450
46.

A new algorithm for the discrimination of actinic keratosis from normal skin and squamous cell carcinoma based on in vivo analysis of optical properties by high-definition optical coherence tomography.

Boone MA, Suppa M, Marneffe A, Miyamoto M, Jemec GB, Del Marmol V.

J Eur Acad Dermatol Venereol. 2016 Oct;30(10):1714-1725. doi: 10.1111/jdv.13720. Epub 2016 Jun 17.

PMID:
27311752
47.

Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients.

Seremet T, Koch A, Jansen Y, Schreuer M, Wilgenhof S, Del Marmol V, Liènard D, Thielemans K, Schats K, Kockx M, Van Criekinge W, Coulie PG, De Meyer T, van Baren N, Neyns B.

J Transl Med. 2016 Aug 2;14(1):232. doi: 10.1186/s12967-016-0990-x.

48.

Factors driving the use of dermoscopy in Europe: a pan-European survey.

Forsea AM, Tschandl P, Del Marmol V, Zalaudek I, Soyer HP; Eurodermoscopy Working Group, Geller AC, Argenziano G.

Br J Dermatol. 2016 Dec;175(6):1329-1337. doi: 10.1111/bjd.14895. Epub 2016 Nov 15. Erratum in: Br J Dermatol. 2017 May;176(5):1416.

PMID:
27469990
49.

Are General Physicians Prepared for Struggling Skin Cancer?-Cross-Sectional Study.

Duarte AF, da Costa-Pereira A, Del-Marmol V, Correia O.

J Cancer Educ. 2018 Apr;33(2):321-324. doi: 10.1007/s13187-016-1078-2.

PMID:
27405456
50.

In vivo assessment of optical properties of basal cell carcinoma and differentiation of BCC subtypes by high-definition optical coherence tomography.

Boone M, Suppa M, Miyamoto M, Marneffe A, Jemec G, Del Marmol V.

Biomed Opt Express. 2016 May 19;7(6):2269-84. doi: 10.1364/BOE.7.002269. eCollection 2016 Jun 1.

Supplemental Content

Loading ...
Support Center